Xeris Pharmaceuticals | XERS - Loan Capital


Xeris Pharmaceuticals reported $219.47M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 158.75M 102.62M Jun/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.67M 95K Jun/2025
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Organigram Holdings CAD 76.4M 23.6M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Pacira USD 372.19M 4.53M Dec/2025
Perrigo USD 3.6B 4.5M Dec/2025
Pharma Mar EUR 37.75M 180K Sep/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Sartorius EUR 3.41B 682.5M Sep/2025
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Tilray USD 279.22M 18.87M Mar/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025